ESAP protocol

chemotherapy protocol consisting of above cpds; used in the therapy of lymphomas & Hodgkin's dieases

Also Known As:

E-SHAP protocol; ESHAP protocol

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - ESAP protocol: 3
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - ESAP protocol: 3
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - ESAP protocol: 3
Inorganic Chemicals: 9
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        Cytarabine: 6662
        ESAP protocol: 3
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Cytarabine: 6662
        ESAP protocol: 3
  - Arabinonucleosides: 1
    - Cytarabine: 6662
      - ESAP protocol: 3
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        ESAP protocol: 3
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        ESAP protocol: 3
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Prednisolone: 12013
        Methylprednisolone: 7513
        ESAP protocol: 3
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Etoposide: 10706
      - ESAP protocol: 3

Experts

1.	Al Yafei, Sumaya: 1 article (01/2013)
2.	El-Geed, Hager A: 1 article (01/2013)
3.	Elazzazy, Shereen: 1 article (01/2013)
4.	Majumdar, Gautam: 1 article (01/2002)

Related Diseases

1.	Neutropenia 03/01/1995 - "The study assessed the role and potential benefit of rhG-CSF in reducing the frequency, duration and severity of neutropenia following cytotoxic chemotherapy according to the E-SHAP protocol and, at the same time in improving the response rate. "
2.	Hypophosphatemia 01/01/2013 - "This is a case report of a 51-year-old woman with relapsed Hodgkin's lymphoma who developed severe hypophosphatemia following administration of the first cycle of the ESHAP protocol. " 01/01/2013 - "Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report." 01/01/2013 - "Critical monitoring of phosphate levels and considering supplementation is warranted with the ESHAP protocol, especially when it is used in combination with granulocyte colony-stimulating factor and diuretics, to prevent such possible hypophosphatemia. " 01/01/2013 - "This case report raises concern regarding hypophosphatemia as a possible side effect of the ESHAP protocol and points to a need for close monitoring, taking into consideration vitamin D levels, urinary phosphate excretion, parathyroid hormone levels, and arterial blood gas analysis to rule out other contributing factors. "
3.	Tetany (Spasmophilia) 01/01/2002 - "Severe hypomagnesaemia with tetany following ESHAP protocol." 01/01/2002 - "BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. "
4.	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/01/2002 - "BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. "
5.	Hodgkin Disease (Hodgkin's Disease) 01/01/2013 - "This is a case report of a 51-year-old woman with relapsed Hodgkin's lymphoma who developed severe hypophosphatemia following administration of the first cycle of the ESHAP protocol. " 01/01/2013 - "Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report."

Related Drugs and Biologics

1.	Granulocyte Colony-Stimulating Factor (G-CSF)
2.	Vitamin D
3.	Phosphates (Orthophosphate)
4.	Parathyroid Hormone (Parathormone)
5.	Diuretics

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)